Anatomic Pathology Division
The Anatomic Pathology Division provides diagnosis
of diseases and monitoring of therapy by examining
tissues and cells, utilizing the latest techniques
for the diagnosis of neoplastic, inflammatory
and transplant-related diseases. The division
is divided into three sections: cytopathology,
medical pathology and surgical pathology.
John J. Brooks, MD
This section serves as a referral center for
diagnosis based on examination of cellular
material. Diseases of the thyroid, lung, gynecologic
organs, kidney and lymph nodes are evaluated.
Prabodh K. Gupta, MD
This laboratory performs chromosome analysis
in diagnosing and classifying leukemias and
other hematologic disorders.
Adam Bagg, MD
Jennifer Morrissette, PhD
This section diagnoses diseases at autopsy and
utilizes various techniques including electron
Leslie A. Litzky, MD
This laboratory examines tissues at high magnification to detect changes in cell components in the diagnosis of lung, renal and cardiac diseases as well as cancers of various organs. Element analysis by X-ray diffraction of small tissue samples is performed in association with electron microscopy to aid in interpretation.
This section is a referral center for diagnosis of malignant tumors of the breast, thyroid, uterus and ovaries, head and neck, lymphatic organs and lung. Diagnoses of neoplastic and non-neoplastic (inflammatory) diseases are also rendered.
Kathleen Montone, MD
The IHC lab is a comprehensive lab that employs state-of-the-art automation and technology to provide outstanding IHC staining for hundreds of targets in human tissue. The IHC lab also performs FISH assays for prognosis and diagnosis of solid tumors and assessment of breast cancer markers (both IHC and FISH) for patient care. Given the IHC labís technical and professional expertise, it is well equipped to develop and apply new tests for clinical trials. The lab offers frequent consultations with various technical and regulatory issues for outside laboratories and serve as a reference lab for various tests for the hospitals in the region.
Paul J. Zhang, MD
This laboratory evaluates diagnostic specimens
using recent techniques to localize tumor antigens
in melanomas, carcinomas and sarcomas, including
intermediate filament protein and hormonal
markers such as keratin, alpha-fetoprotein,
human chorionic gonadotropin and calcitonin.
Reagents are available for localization of
various infectious agents.
Metabolic Bone Laboratory
Non-neoplastic bone lesions, osteoporosis, and
nutritional bone disorders are evaluated qualitatively
Solid tumor evaluation of small round cell tumors
and bone and soft tissue sarcomas is offered
in order to subclassify these lesions at the
Evaluation of kidney and urology diseases, transplant
rejection phenomena, and other disorders by
means of light microscopic immunofluorescence
and electron microscopy.